National Health Investors (NHI) Given a $75.00 Price Target by SunTrust Banks Analysts

National Health Investors (NYSE:NHI) received a $75.00 price target from investment analysts at SunTrust Banks in a research report issued on Monday. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price objective suggests a potential upside of 5.77% from the stock’s previous close.

A number of other equities analysts have also commented on the stock. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a report on Thursday, September 28th. Stifel Nicolaus reiterated a “buy” rating and issued a $82.00 price objective on shares of National Health Investors in a report on Wednesday, October 4th. Mizuho reiterated a “hold” rating and issued a $82.00 price objective on shares of National Health Investors in a report on Wednesday, October 4th. BMO Capital Markets reiterated a “hold” rating and issued a $80.00 price objective on shares of National Health Investors in a report on Wednesday, October 18th. Finally, Capital One Financial initiated coverage on shares of National Health Investors in a report on Monday, October 23rd. They issued an “equal weight” rating on the stock. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $80.63.

National Health Investors (NYSE NHI) traded up $1.11 during trading hours on Monday, hitting $70.91. 225,074 shares of the company traded hands, compared to its average volume of 231,155. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.72. The firm has a market cap of $2,950.00, a price-to-earnings ratio of 17.73, a price-to-earnings-growth ratio of 3.22 and a beta of 0.59. National Health Investors has a 1-year low of $68.96 and a 1-year high of $81.60.

National Health Investors (NYSE:NHI) last posted its earnings results on Wednesday, November 8th. The real estate investment trust reported $0.94 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by ($0.40). National Health Investors had a net margin of 59.70% and a return on equity of 12.74%. equities research analysts forecast that National Health Investors will post 5.26 EPS for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in NHI. BlackRock Inc. increased its position in shares of National Health Investors by 6.6% in the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock worth $280,927,000 after purchasing an additional 218,482 shares during the last quarter. Allianz Asset Management GmbH increased its position in shares of National Health Investors by 57.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock worth $30,514,000 after purchasing an additional 144,650 shares during the last quarter. State Street Corp increased its position in shares of National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after purchasing an additional 78,355 shares during the last quarter. Vanguard Group Inc. increased its position in shares of National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after purchasing an additional 72,518 shares during the last quarter. Finally, Employees Retirement System of Texas increased its position in shares of National Health Investors by 353.3% in the 2nd quarter. Employees Retirement System of Texas now owns 81,600 shares of the real estate investment trust’s stock worth $6,463,000 after purchasing an additional 63,600 shares during the last quarter. 70.12% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “National Health Investors (NHI) Given a $75.00 Price Target by SunTrust Banks Analysts” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/01/22/national-health-investors-nhi-given-a-75-00-price-target-by-suntrust-banks-analysts.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Leave a Reply